SPECIFIC FEATURES OF THE IMMUNE STATUS IN RHEUMATOID ARTHRITIS IN RELATION TO THE CLIMATIC, GEOGRAPHICAL, AND ENVIRONMENTAL ZONES OF UZBEKISTAN
https://doi.org/10.14412/1995-4484-2016-183-186
Abstract
The feature of rheumatoid arthritis (RA) is the predominant clinical picture of chronic synovial joint inflammation accompanied by progressive cartilage and bone destruction, the pathogenesis of which is greatly due to autoimmune mechanisms. Some investigations demonstrate that a set of poor climatic and geographical factors may influence the development of immune disorders that are a trigger in the development of RA.
Objective: to comparative analyze immunological parameters in RA in dwellers from different regions of Uzbekistan.
Subjects and methods. The study enrolled RA patients from three Uzbekistan zones: 1) Tashkent (n = 25), 2) Xorazm Region (n = 25); 3) Namangan Region (n = 28).
Results and discussion. Comparative analysis of the immune status indicated that the patients living in Zone 2 exhibited a significantly reduced T cell immune response (p < 0.05), a considerably higher count of B lymphocytes (p < 0.001), and significantly lower levels of CD11b+, CD18+, CD25+, and CD95+ cells (p < 0.05) than did those from the two other zones. Examination of the frequency of the monomorphic determinant of histocompatibility Class I (HLA-I) antigens revealed its significant decrease in the patients residing in Zones 1 and 3 (p < 0.05) whereas the RA patients from Zone 2 had a significantly higher frequency of HLA-DR (p < 0.05).
Conclusion. The comparative analysis shows that the immunological parameters differ in the patients from the three zones of Uzbekistan, which may suggest that the climatic and geographical factors of the environment may influence the course of the disease.
References
1. Насонова ВА, Лукина ГВ, Сигидин ЯА. Нейтрализация ИФ-γ – новое направление в терапии ревматоидного артрита. Терапевтический архив. 2008;80(5):30-7 [Nasonova VA, Lukina GV, Sigidin YaA. Neutralization of IF-γ – a new direction in the treatment of rheumatoid arthritis. Terapevticheskii Arkhiv. 2008;80(5):30-7 (In Russ.)].
2. Panayi GS, Corrigall VM, Pitzalis C. Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin N Am. 2001;27:317-34. doi: 10.1016/S0889-857X(05)70204-0
3. Zhang ZX, Bridges SL. Pathogenesis of rheumatoid arthritis. Role of B lymphocytes. Rheum Dis Clin N Am. 2001;27:335-53. doi: 10.1016/S0889-857X(05)70205-2
4. Hakoda M. Absolute risk for fracture and WHO guideline. Epidemiology of rheumatoid arthritis. Clin Calcium. 2007;17(7):1081-7.
5. Синяченко ОВ. Ревматические заболевания и экология. Украинский ревматологический журнал. 2007;(4):64-8 [Sinyachenko OV. Rheumatic diseases and ecology. Ukrainskii Revmatologicheskii Zhurnal. 2007;(4):64-8 (In Russ.)].
6. Badley E, Tennant A. Impact of disablement due to rheumatic disorders in British population: estimate of severity and prevalence from the calderdale rheumatic disablement survey. Ann Rheum Dis. 1993;52(1):6-13. doi: 10.1136/ard.52.1.6
7. Carmona L, Ballina J, Gabriel R. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis. 2001;60(11):1040-5.
8. Holmberg S, Thelin A, Thelin N. Is there an increased risk of knee osteoarthritis among farmers? A population-based case-control study. Int Arch Occup Environ Health. 2004; 77(5):345-50. doi: 10.1007/s00420-004-0518-1
9. Вронский ВА. Глобальное потепление климата и окружающая среда на рубеже ХХI века. География в школе. 2000;(8):33-9 [Vronskii VA. Global warming and the environment at the turn of the twenty-first century. Geografiya v Shkole. 2000;(8):33-9 (In Russ.)].
10. Малхазова СМ. Медико-географический анализ территорий: картографирование, оценка, прогноз. Москва: Научный мир; 2001. С. 35 [Malkhazova SM. Mediko-geograficheskii analiz territorii: kartografirovanie, otsenka, prognoz [Medical and geographical analysis of areas: mapping, assessment, prognosis]. Moscow: Nauchnyi mir; 2001. P. 35].
11. Федосеева ВН, Пинегин БВ, Орадовская ИВ. Выявление групп промышленного риска развития иммунопатологии при массовых обследованиях населения. Гигиена и санитария. 1989;(3):17-9 [Fedoseeva VN, Pinegin BV, Oradovskaya IV. Identifying groups at risk of industrial development of immunopathology at mass inspections of the population. Gigiena i Sanitariya. 1989;(3):17-9 (In Russ.)].
12. Хаитов РМ, Пинегин БВ, Истамов ХИ. Экологическая иммунология. Москва: Изд-во ВНИРО; 1995. 219 с. [Khaitov RM, Pinegin BV, Istamov KhI. Ekologicheskaya immunologiya [Environmental Immunology]. Moscow: Publishing House of VNIRO; 1995. 219 p.].
13. Хаитов РМ. Иммунология: Учебник. Москва: ГЭОТАР- Медиа; 2009. 320 с. [Khaitov RM. Immunologiya: Uchebnik [Immunology: A Textbook]. Moscow: GEOTAR-Media; 2009. 320 p.].
14. Proffitt F, Bagla P. Ecology: Circling in on a vulture killer. Science. 2004;306(5694):223-4. doi: 10.1126/science.306.5694.223
15. Klimiuk PA, Sierakowski S, Latosiewicz R, et al. Mistological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. J Rheumatol. 2005;32(9):1666-72.
16. Dolhain R, ter Haar NT, Hoefakker S. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane comparedwith synovium of patients with osteoarthritis. Br J Rheumatol. 1996;35(1):24-32. doi: 10.1093/rheumatology/35.1.24
17. Bank I, Coheu L, Monallem M. T cell subsets in patients with arthritis and chronic neutropenia. Ann Rheum Dis. 2002;61(5):438- 43. doi: 10.1136/ard.61.5.438
18. Adriaansen J, Tas SW, Klarenbeek PL, et al. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Ann Rheum Dis. 2005;(12):1677-84. doi: 10.1136/ard.2004.035063
Review
For citations:
Akhmedov Kh.S. SPECIFIC FEATURES OF THE IMMUNE STATUS IN RHEUMATOID ARTHRITIS IN RELATION TO THE CLIMATIC, GEOGRAPHICAL, AND ENVIRONMENTAL ZONES OF UZBEKISTAN. Rheumatology Science and Practice. 2016;54(2):183-186. (In Russ.) https://doi.org/10.14412/1995-4484-2016-183-186